In vitro and in vivo effects of easily administered, low-toxic retinoid and phenylacetate compounds on human neuroblastoma cells

British Journal of Cancer

Volumn 89, Issue 2, 2003, Pages 412-419

  Sidell, N ^a   Pasquali, M ^b   Malkapuram, S ^a   Barua, A B ^c   Wanichkul, T ^a   Wada, R K ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c IOWA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Chemoprevention; Neuroblastoma; Phenylacetate; Retinoyl glucuronide

Indexed keywords

PHENYLACETIC ACID DERIVATIVE; RETINOID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MORPHOLOGY; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR GENE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; CELL DIVISION; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MICE; MICE, NUDE; NEUROBLASTOMA; PHENYLACETATES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0041620148     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601108     Document Type: Article

References (37)

1. Abemayor E, Chang B, Sidell N (1990) Effects of retinoic acid on the in vivo growth of human neuroblastoma cells. Cancer Lett 55: 1-5
2. Barua AB (1997) Retinoyl β-glucuronide: a biologically active form of vitamin A. Nutr Rev 55: 259-267
3. Barua AB, Duitsman PK, Kostic D, Barua M, Olson JA (1997) Reduction of serum retinol levels following a single oral dose of retinoic scid in humans. Int J Vitam Nutr Res 67: 423-425
4. Batshaw ML, Monahan PS (1987) Treatment of urea cycle disorders. Enzyme 38: 242-250
5. Becker B, Barua AB, Olson JA (1996) All-trans-retinoyl β-glucuronide: new procedure for chemical synthesis and its metabolism in vitamin A-deficient rats. Biochem J 314: 249-252
6. Cheung B, Hocker JE, Smith SA, Norris MD, Haber M, Marchall GM (1998) Favorable prognostic significance of high-level retinoic acid receptor β expression in neuroblastoma mediated by effects on cell cycle regulation. Oncogene 17: 751-759
7. Connor MJ, Smit MH (1987) Retinoic acid formation from retinol in the skin. Biochem Pharmacol 36: 919-924
8. Di Benedetto M, Starzec A, Colombo BM, Briane D, Perret GY, Kraemer M, Crepin M (2002) Aponecrotic, antiangiogenic and antiproliferative effects of a novel dextran derivative on breast cancer growth in vitro and in vivo. Br J Pharmacol 135: 1859-1871
9. Evans AE, Gerson S, Schnaufer L (1976) Spontaneous regression of neuroblastoma. J Natl Cancer Inst Monogr 44: 9-54
10. Gale G, D'Angio G, Uri A, Chatten J, Coop CE (1982) Cancer in neonates: the experience at the children's hospital of Philadelphia. Pediatrics 70: 409-413
11. Han S, Greene ME, Pitts J, Wada RK, Sidell N (2001) Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARγ) in human neuroblastoma cells. Clin Cancer Res 7: 98-104
12. Hudgins WR, Shack S, Myers CE, Samid D (1995) Cytostatic activity of phenylacetate and derivatives against tumor cells: correlation with lipophilicity and inhibition of protein prenylation. Biochem Pharmacol 50: 1273-1279
13. Jung M (2001) Inhibitors of histone deacetylase as new anticancer agents. Curr Med Chem 8: 1505-1511
14. Keilson B, Underwood BA, Loerch JD (1979) Effects of retinoic acid on the mobilization of vitamin A from the liver of rats. J Nutr 109: 787-795
15. Khanna C, Jaboin JJ, Drakos E, Tsokos M, Thiele CJ (2002) Biologically relevant orthotopic neuroblastoma xenograft models: primary adrenal tumor growth and spontaneous distant metastasis. In vivo 16: 77-85
16. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Berbing RB, Reynolds CP (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N Engl J Med 341: 1165-1173
17. Moats R, Ma LQ, Wajed R, Sugiura Y, Lazaryev A, Tyszka M, Jacobs R, Fraser S, Nelson Jr MD, DeClerck YA (2000) Magnetic resonance imaging for the evaluation of a novel metastatic orthotopic model of human neuroblastoma in immunodeficient mice. Clin Exp Metastasis 18: 455-461
18. Nau H, Elmazar RR, Thiel R, Sass JO (1996) All-trans retinoyl β-glucuronide is a potent teratogen in the mouse because of extensive metabolism to all-trans retinoic acid. Teratology 54: 150-156
19. Piazza F, Gurrieri C, Pandolfi PP (2001) The theory of APL. Oncogene 20: 7216-7222
20. Pineau T, Hudgins WR, Liu L, Chen L-C, Sher T, Gonzalez FJ, Samid D (1996) Activation of a human peroxidome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs. Biochem Pharmacol 52: 659-667
21. Prasanna P, Shack S, Wilson VL, Samid D (1995) Phenylacetate in chemoprevention: in vitro and in vivo suppression of 5-aza-2′-deoxycytidine-induced carcinogenesis. Clin Cancer Res 1: 865-871
22. Regazzi MB, Iacona I, Gervasutti C, Lazzarino M, Toma S (1997) Clinical pharmacokinetics of tretinoin. Drug Dispos 32: 382-402
23. Reynolds CP, Lemons RS (2001) Retinoid therapy of childhood cancer. Hematol Oncol Clin North Am 15: 867-910
24. Robson JA, Sidell N (1985) Ultrastructural features of a human neuroblastoma cell line treated with retinoic acid. Neuroscience 14: 1149-1162
25. Ruiz-Maldonado R, Tamayo-Sanchez L, Orozco-Covarrubias ML (1998) The use of retinoids in the pediatric patient. Dermatol Clin 16: 553-569
26. Sidell N, Altman A, Haussler MR, Seeger RC (1983) Effects of retinoic acid on the growth and phenotypic expression of several human neuroblastoma cell lines. Expl Cell Res 148: 21-30
27. Sidell N, Chang B, Yamashir JM, Wada RK (1998) Transcriptional upregulation of retinoic acid receptor β (RARβ) expression by phenylacetate in human neuroblastoma cells. Exp Cell Res 239: 169-174
28. Sidell N, Lucas CA, Kreutzberg GW (1984) Regulation of acetylcholinesterase activity by retinoic acid in a human neuroblastoma cell line. Exp Cell Res 155: 305-309
29. Sidell N, Sawatsri S, Connor MJ, Barua AB, Olson JA, Wada RK (2000) Pharmacokinetics of chronically administered all-trans-retinoyl-β-glucuronide in mice. Biochim Biophys Acta 1502: 264-272
30. Sidell N, Wada R, Han G, Chang B, Shack S, Moore T, Samid D (1995) Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cells. Int J Cancer 60: 507-514
31. Tanaka K, West-Dull A, Hine DG, Lynn TB, Lowe (1980) Gas-chromatographic method of analysis for urinary organic acids. II. Description of the procedure, and its application to diagnosis of patients with organic acidurias. Clin Chem 26: 1847-1853
32. Teelmann K, Tsukaguchi T, Klaus M, Eliason JF (1993) Comparison of the therapeutic effects of a new arotinoid, Ro 40-8757, and all-trans- and 13-cis-retinoic acids on rat breast cancer. Cancer Res 53: 2319-2325
33. Thibault A, Cooper MR, Figg WD, Venzon DJ, Sartor AO, Tompkins AC, Weinberger MS, Headlee DJ, McCall NA, Samid D et al. (1994) A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer. Cancer Res 54: 1690-1694
34. Thompson JA, Markey SP (1975) Quantitative metabolic profiling of urinary organic acids by gas chromatography-mass spectrometry: comparison of isolation methods. Anal Chem 47: 1313-1321
35. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). Br J Cancer 77: 1-10
36. Wuarin L, Chang B, Wada R, Sidell N (1994) Retinoic acid up-regulates nuclear retinoic acid receptor-α expression in human neuroblastoma cells. Int J Cancer 56: 840-845
37. Wuarin L, Verity MA, Sidell N (1991) Effects of gamma-interferon and its interaction with retinoic acid on human neuroblastoma differentiation. Int J Cancer 48: 136-144